Detalles de la búsqueda
1.
Impact of switching virologically suppressed, HIV-1-infected patients from twice-daily fixed-dose zidovudine/lamivudine to once-daily fixed-dose tenofovir disoproxil fumarate/emtricitabine.
HIV Clin Trials
; 9(2): 103-14, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18474495
2.
Patient-reported outcomes in virologically suppressed, HIV-1-Infected subjects after switching to a simplified, single-tablet regimen of efavirenz, emtricitabine, and tenofovir DF.
AIDS Patient Care STDS
; 24(2): 87-96, 2010 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-20156091
3.
Simplification of antiretroviral therapy to a single-tablet regimen consisting of efavirenz, emtricitabine, and tenofovir disoproxil fumarate versus unmodified antiretroviral therapy in virologically suppressed HIV-1-infected patients.
J Acquir Immune Defic Syndr
; 51(2): 163-74, 2009 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19357529
Resultados
1 -
3
de 3
1
Próxima >
>>